Microrna-205 regulates the expression of parkinson's disease-related leucine-rich repeat kinase 2 protein

Human Molecular Genetics

Volumn 22, Issue 3, 2013, Pages 608-620

  Cho, Hyun Jin ^a   Liu, Guoxiang ^a   Jin, Seok Min ^b   Parisiadou, Loukia ^a   Xie, Chengsong ^a   Yu, Jia ^a   Sun, Lixin ^a   Ma, Bo ^a   Ding, Jinhui ^a   Vancraenenbroeck, Renee ^c   Lobbestael, Evy ^c   Baekelandt, Veerle ^c   Taymans, Jean Marc ^c   He, Ping ^d   Troncoso, Juan C ^e   Shen, Yong ^d   Cai, Huaibin ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d ROSKAMP INSTITUTE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; MESSENGER RNA; MICRORNA 205;

3' UNTRANSLATED REGION; AGED; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FRONTAL CORTEX; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; MODULATION; NERVE FIBER GROWTH; PARKINSON DISEASE; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; BRAIN; DOPAMINERGIC NEURONS; DOWN-REGULATION; GENETIC MARKERS; GENOME-WIDE ASSOCIATION STUDY; HEK293 CELLS; HELA CELLS; HUMANS; MICE; MICE, TRANSGENIC; MICRORNAS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NEURONS; PARKINSON DISEASE; PREFRONTAL CORTEX; PROTEIN-SERINE-THREONINE KINASES; UP-REGULATION;

EID: 84872394361     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds470     Document Type: Article

References (38)

1. Schapira, A.H. (1997) Pathogenesis of Parkinson's disease. Baillieres. Clin. Neurol., 6, 15-36.
2. Ferrer, I., Martinez, A., Blanco, R., Dalfo, E. and Carmona, M. (2011) Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease. J. Neural. Transm., 118, 821-839.
3. Lanoue, A.C., Dumitriu, A., Myers, R.H. and Soghomonian, J.J. (2010) Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease. Exp. Neurol., 226, 207-217.
4. Beach, T.G., Adler, C.H., Lue, L., Sue, L.I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Boyer, S., Shirohi, S., Brooks, R. et al. (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta. Neuropathologica., 117, 613-634.
5. Dumitriu, A., Latourelle, J.C., Hadzi, T.C., Pankratz, N., Garza, D., Miller, J.P., Vance, J.M., Foroud, T., Beach, T.G. and Myers, R.H. (2012) Gene expression profiles in Parkinson disease preforntal cortex implicate FOXO1 and gene under its transcriptional regulation. PLoS Genet., 8, e1002794.
6. Hardy, J., Cai, H., Cookson, M.R., Gwinn-Hardy, K. and Singleton, A. (2006) Genetics of Parkinson's disease and parkinsonism. Ann. Neurol., 60, 389-398.
7. Paisan-Ruiz, C., Jain, S., Evans, E.W., Gilks, W.P., Simon, J., van der, B.M., Lopez, D.M., Aparicio, S., Gil, A.M., Khan, N. et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron, 44, 595-600.
8. Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R.J., Calne, D.B. et al. (2004) Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron, 44, 601-607.
9. Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A. et al. (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet., 41, 1303-1307.
10. Simon-Sanchez, J., Schulte, C., Bras, J.M., Sharma, M., Gibbs, J.R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S.W., Hernandez, D.G. et al. (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet., 41, 1308-1312.
11. Lin, X., Parisiadou, L., Gu, X.L., Wang, L., Shim, H., Sun, L., Xie, C., Long, C.X., Yang, W.J., Ding, J. et al. (2009) Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. Neuron, 64, 807-827.
12. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
13. Kosik, K.S. (2006) The neuronal microRNA system. Nat. Rev. Neurosci., 7, 911-920.
14. Hebert, S.S. and De Strooper, B. (2009) Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci., 32, 199-206.
15. Kim, J., Inoue, K., Ishii, J., Vanti, W.B., Voronov, S.V., Murchison, E., Hannon, G. and Abeliovich, A. (2007) A MicroRNA feedback circuit in midbrain dopamine neurons. Science, 317, 1220-1224.
16. Junn, E., Lee, K.W., Jeong, B.S., Chan, T.W., Im, J.Y. and Mouradian, M.M. (2009) Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc. Natl Acad. Sci. USA, 106, 13052-13057.
17. Gehrke, S., Imai, Y., Sokol, N. and Lu, B. (2010) Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature, 466, 637-641.
18. Arlotta, P., Molyneaux, B.J., Jabaudon, D., Yoshida, Y. and Macklis, J.D. (2008) Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum. J. Neurosci., 28, 622-632.
19. Bartel, D.P. (2009) MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-233.
20. Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P. and Burge, C.B. (2003) Prediction of mammalian microRNA targets. Cell, 115, 787-798.
21. Lewis, B.P., Burge, C.B. and Bartel, D.P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20.
22. Fletcher, A.M., Heaford, A.C. and Trask, D.K. (2008) Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific mir-205. Transl. Oncol., 1, 202-208.
23. Wu, H. and Mo, Y.Y. (2009) Targeting miR-205 in breast cancer. Expert Opin. Ther. Targets, 13, 1439-1448.
24. Chendrimada, T.P., Gregory, R.I., Kumaraswamy, E., Norman, J., Cooch, N., Nishikura, K. and Shiekhattar, R. (2005) TRBP recruits the dicer complex to Ago2 for microRNA processing and gene silencing. Nature, 436, 740-744.
25. Cheng, A.M., Byrom, M.W., Shelton, J. and Ford, L.P. (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res., 33, 1290-1297.
26. Parisiadou, L., Xie, C., Cho, H.J., Lin, X., Gu, X.L., Long, C.X., Lobbestael, E., Baekelandt, V., Taymans, J.M., Sun, L. et al. (2009) Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J. Neurosci., 29, 13971-13980.
27. Li, Y., Liu, W., Oo, T.F., Wang, L., Tang, Y., Jackson-Lewis, V., Zhou, C., Geghman, K., Bogdanov, M., Przedborski, S. et al. (2009) Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat. Neurosci., 12, 826-828.
28. Galter, D., Westerlund, M., Carmine, A., Lindqvist, E., Sydow, O. and Olson, L. (2006) LRRK2 expression linked to dopamine-innervated areas. Ann. Neurol., 59, 714-719.
29. Giasson, B.I. and Van Deerlin, V.M. (2008) Mutations in LRRK2 as a cause of Parkinson's disease. Neurosignals, 16, 99-105.
30. Sharma, S., Bandopadhyay, R., Lashley, T., Renton, A.E., Kingsbury, A.E., Kumaran, R., Kallis, C., Vilarino-Guell, C., O'Sullivan, S.S., Lees, A.J. et al. (2011) LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: A morphological and quantitative study. Neuropathol. Appl. Neurobiol., 37, 777-790.
31. Devine, M.J., Kaganovich, A., Ryten, M., Mamais, A., Trabzuni, D., Manzoni, C., McGoldrick, P., Chan, D., Dillman, A., Zerle, J. et al. (2011) Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue. PLoS ONE, 6, e22489.
32. Beach, T.G., Sue, L.I., Walker, D.G., Roher, A.E., Lue, L., Vedders, L., Connor, D.J., Sabbagh, M.N. and Rogers, J. (2008) The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007. Cell Tissue Bank, 9, 229-245.
33. Taymans, J.M., Van den, H.C. and Baekelandt, V. (2006) Distribution of PINK1 and LRRK2 in rat and mouse brain. J. Neurochem., 98, 951-961.
34. Song, H. and Bu, G. (2009) MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1. Biochem. Biophys. Res. Commun., 388, 400-405.
35. Bhatnagar, N., Li, X., Padi, S.K., Zhang, Q., Tang, M.S. and Guo, B. (2010) Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells. Cell Death Dis., 1, e105.
36. Cai, H., Lin, X., Xie, C., Laird, F.M., Lai, C., Wen, H., Chiang, H.C., Shim, H., Farah, M.H., Hoke, A. et al. (2005) Loss of ALS2 function is insufficient to trigger motor neuron degeneration in knock-out mice but predisposes neurons to oxidative stress. J. Neurosci., 25, 7567-7574.
37. Lai, C., Xie, C., McCormack, S.G., Chiang, H.C., Michalak, M.K., Lin, X., Chandran, J., Shim, H., Shimoji, M., Cookson, M.R. et al. (2006) Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking. J. Neurosci., 26, 11798-11806.
38. Garcia, D.M., Baek, D., Shin, C., Bell, G.W., Grimson, A. and Bartel, D.P. (2011) Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other miRNAs. Nat. Struct. Mol. Biol., 18, 1139-1146.